Current Research

Tiny Technologies and Regenerative Medicine

Sangeeta Bhatia focuses on the intersection of engineering, medicine, and biology to develop novel platforms for understanding, diagnosing, and treating human disease. Her technologies interface living cells with synthetic systems, enabling applications in tissue regeneration, stem cell differentiation, diagnostics, and drug delivery, such as human microlivers that model human drug metabolism, drug-induced liver disease, and interaction with human pathogens. Her group also develops nanoparticles and nanoporous materials that can be designed to assemble and communicate to study, diagnose, and treat a variety of diseases, including cancer.

Find a Scientist